|
|
|
| Application value of whole-course seamless nursing intervention mode in the treatment of patients with ankylosing spondylitis with adamumab in outpatient department |
| XIA Yingying1 CHENG Jing2▲#br# |
| 1.Department of Pediatric Critical Care Unit, Xinhua Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200092, China; 2.Outpatient Comprehensive Care Group, Xinhua Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200092, China |
|
|
|
Abstract Objective To investigate the application value of whole-course seamless nursing intervention mode in the treatment of patients with ankylosing spondylitis with adamumab in outpatient department. Methods A total of 100 patients with ankylosing spondylitis in Xinhua Hospital Affiliated to Medical College of Shanghai Jiao Tong University from June 2019 to June 2020 were selected. According to the odd and even grouping method, they were divided into observation group and control group, with 50 cases in each group. The control group was given routine nursing guidance, and the observation group was given whole-process seamless nursing intervention mode on the basis of the control group. Bath ankylosing spondylitis metroloty index (BASDAI), bath ankylosing spondyltis functional index (BASFI), patient global assessment (PGA), the 36-item short form health survey, and satisfaction of nursing service were compared between the two groups before, 3 months, 6 months, and 1 year of nursing. Results Overall analysis showed that there were statistically significant differences between groups, time points and interactions (P ＜ 0.05). The BASDAI, BASFI, and PGA of nursing 3 months, 6 months, and 1 year in both groups were lower than those before nursing (P ＜ 0.05); BASDAI, BASFI, and PGA of nursing for 6 months were lower than those of nursing for 3 months, and BASDAI, BASFI, and PGA of nursing for 1 year were lower than those of nursing for 3 months and nursing for 6 months (P ＜ 0.05); comparison between groups: BASDAI, BASFI, and PGA in observation group were lower than those in control group (P ＜ 0.05); after nursing, the quality of life index of both groups were higher than before, and the observation group was higher than the control group (P ＜ 0.05). Nursing service satisfaction of observation group was higher than control group (P ＜ 0.05). Conclusion The whole process of seamless nursing can promote the treatment of ankylosing spondylitis with adalimumab, can control the disease, improve the quality of life and satisfaction, and can be promoted.
|
|
|
|
|
|
[1] 张斌斌，戴娜，杨迎，等.强直性脊柱炎累及脊柱的Andersson病变MRI表现[J].实用放射学杂志，2021，37（2）：279-282.
[2] 黄季晨，钱邦平，邱勇，等.强直性脊柱炎合并寰枢椎脱位的影像学特点及手术疗效[J].中国脊柱脊髓杂志，2021， 31（4）：294-301.
[3] 孔瑞娜，赵东宝，高洁，等.阿达木单抗对强直性脊柱炎患者骨代谢标志物的影响[J].中国骨质疏松杂志，2019， 25（7）：905-908.
[4] 李俊杰，季加芬，刘长云.强直性脊柱炎的遗传流行病学研究[J].国际儿科学杂志，2013，40（4）：413-415.
[5] 宋永嘉，王凯，宋志靖，等.强直性脊柱炎引起骨代谢紊乱的分子学机制[J].中国骨质疏松杂志，2020，26（9）：1382-1385，1390.
[6] 李学勇，熊玮玮，董亮，等.九江地区强直性脊柱炎中医证型分布规律及流行病学特征研究[J].江西中医药，2019， 50（10）：40-42.
[7] 钱佳丽，余毅，毛盈颖，等.强直性脊柱炎家系流行病学调查和中医体质分析[J].中华中医药杂志，2017（12）：5599-5602.
[8] 陈泽鑫，崔阳.强直性脊柱炎患者生物制剂的优化治疗[J].中华风湿病学杂志，2021，25（2）：90-96.
[9] 罗凤婷、姜娜、王浩，等.强直性脊柱炎患者外周血单个核细胞的磷酸化蛋白质组学分析[J].细胞与分子免疫学杂志，2020，36（5）：444-450.
[10] Van der Linden S ，Vaikenburg HA，Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis：a proposal for modification of New York criteria [J]. Athritis Rheum，1984，27（4）：361-368.
[11] 汪玉萍，王兴林，梁晓镛，等.Bath强直性脊柱炎计量指数量表的信度和敏感度研究[J].中国康复医学杂志，2003， 18（5）：280-282.
[12] 骆艳丽，吴文源，李春波，等.医学结局研究用疼痛量表在腰痛患者中的信效度初步研究[J].中国心理卫生杂志，2006，20（11）：713-715.
[13] 许军，胡敏燕.健康测量量表SF-36[J].中国行为医学科学，1999，8（2）：150-152.
[14] 苟玉萧，吴霞，陈龙，等.过表达miR-155对强直性脊柱炎滑膜细胞凋亡的影响及作用机制探讨[J].疑难病杂志，2020，19（3）：285-291.
[15] 郭春生，柳盛春，陈凯.动态牵引联合针灸对强直性脊柱炎患者THA术后炎性因子、腰椎功能的影响[J].中国医学创新，2021，18（11）：32-36.
[16] 苏晖莹，王振杰，郭培霞.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白联合沙利度胺治疗强直性脊柱炎的疗效及其对CD14 Dkk-1基因表达的影响[J].安徽医学 2021，42（1）：81-85.
[17] 唐翠萍，陈飞龙，郑松塬，等.强直性脊柱炎患者减停TNF-α抑制剂后的复发情况及预测因素：52周前瞻性临床随访[J].南方医科大学学报，2021（5）：633-639.
[18] 吴逢波，吴斌，孙闻续，等.阿达木单抗治疗强直性脊柱炎的药物经济学文献研究现状[J].中国药房，2019，30（17）：2384-2387.
[19] 杜红丽.阿达木单抗在强直性脊柱炎治疗中的临床效果[J].河南医学研究，2021，30（29）：5486-5489.
[20] 王瑞瑞，金实，丁雪玲，等.温肾健脾定脊汤治疗强直性脊柱炎肾虚督亏，脾病湿困证的临床观察[J].中华中医药杂志，2020，35（4）：2117-2119.
[21] 刘小莉，张红梅，唐敏，等.不同疾病分期强直性脊柱炎患者外周血DKK-1，MMP-3，TNF-α和IL-6的表达及治疗前后水平变化[J].现代免疫学，2020，40（4）：300-305.
[22] 熊江彪，余淑娇，陈景，等.艾拉莫德治疗强直性脊柱炎有效性和安全性的Meta分析[J].中华临床免疫和变态反应杂志，2021，15（1）：53-58.
[23] 曾沛英，蔡章洪，周耿民，等.传统抗风湿药物对强直性脊柱炎的疗效：十年临床观察[J].中华风湿病学杂志，2020，24（3）：159-164.
[24] 应银燕，王筱萍，杨爱玲.基于循证的“一病一品”康复护理方案在强直性脊柱炎患者中的应用[J].中华现代护理杂志，2021，27（19）：2609-2613.
[25] 安玉玲，白芮.全程无缝隙护理在预防骨科手术切口感染中的应用效果[J].中国医药科学，2021，11（22）：118-120，184.
[26] 郑晓娴，黄宏双.无缝隙护理干预对早产儿神经行为的影响[J].中国当代医药，2020，27（1）：241-243.
[27] 朱笑夏，金玥，陶庆文，等.补肾舒脊颗粒治疗肾虚督寒证强直性脊柱炎的临床疗效及对放射学进展的影响[J].中华中医药杂志，2020，35（1）：464-468.
[28] 杨阳，沈逸，程鹏，等.全脊柱加骶髂关节SPARCC评分对益赛普治疗强直性脊柱炎疗效的评估与预测价值[J].中国医学计算机成像杂志，2020，26（1）：55-59.
[29] 罗静，张丽宁，周丽，等.补肾强督方治疗强直性脊柱炎研究进展[J].中华中医药杂志，2020，35（10）：5087-5091. |
|
|
|
